Allergan confirms it's in talks with a 3rd-party buyer, said to be Actavis, in the run up to a December showdown with hostile takeover bidders Valeant Pharmaceuticals and Pershing Square Capital Management.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pr8eRQ
Cap comentari:
Publica un comentari a l'entrada